Content area

|
|

Benzodiazepiner er fortsat førstevalg til behandling af alkoholabstinenssymptomer

Forfattere
Gro Askgaard1, Anton Pottegård2 & Anders Fink-Jensen3 1) Hepatologisk Klinik, Rigshospitalet 2) Afdeling for Klinisk Farmakologi og Farmaci, Institut for Sundhedstjenesteforskning, Syddansk Universitet 3) Psykiatrisk Center København, Region Hovedstadens Psykiatri Ugeskr Læger 2017;179:V07160465
Reference: 
Ugeskr Læger 2017;179:V07160465
Blad nummer: 
Sidetal: 
2-5
Benzodiazepines should still be first-line treatment for alcohol withdrawal
In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzo­diazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Stine Bjerrum Runge | 22/06
2 kommentarer
af Preben Joffe | 22/06
1 Kommentar
af Charlotte Schulsinger | 22/06
6 kommentarer
af Jens-Jørgen Gravesen | 20/06
1 Kommentar
af Tata Marion Ringberg | 18/06
4 kommentarer
af Michael Lee Heyman | 18/06
2 kommentarer
af Gitte E. Egsdal Wienholtz | 18/06
3 kommentarer
af Finn Olav Hansen | 17/06
2 kommentarer